M&A Deal Summary |
|
|---|---|
| Date | 2023-12-22 |
| Target | ATOM Group |
| Sector | Distribution |
| Buyer(s) | Pacific Equity Partners |
| Deal Type | Buyout (LBO, MBO, MBI) |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Private Equity Firm |
|---|---|
| Founded | 1998 |
| PE ASSETS | 10.0B AUD |
| Size | Mega |
| Type | Sector Agnostic |
Pacific Equity Partner (PEP) is a private equity firm focused on buyout and late stage expansion capital investments in Australia and New Zealand. PEP typically partners with management teams in acquiring businesses and focuses on transactions valued up to AU$1 Billion. The Firm prefers control situations and typically holds investments for three to six years. PEP will not invest in start-ups or unprofitable businesses, as well as gambling or tobacco companies. Pacific Equity Partners was formed in 1998 and is based in Sydney, Australia. The Firm targets various industries.
| DEAL STATS | # |
|---|---|
| Overall | 35 of 35 |
| Sector (Distribution) | 2 of 2 |
| Type (Buyout (LBO, MBO, MBI)) | 18 of 18 |
| Country (Australia) | 25 of 25 |
| Year (2023) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-10-28 |
iNova Pharmaceuticals
Singapore, Singapore iNova Pharmaceuticals is a developer and marketer of over-the-counter and prescription medicines. iNova Pharmaceuticals was founded in 1958 and is based in Singapore. |
Sell | $1.4B |
